ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 111,200
+7,900 (7.65%)
Nov 4, 2025, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 6.13 trillion as of November 4, 2025. Its market cap has increased by 292.55% in one year.
Market Cap
6.13T
Enterprise Value
6.04T
Revenue
94.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
111,200.00
Market Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 6.13T, an increase of 907.20%. That is a compound annual growth rate of 39.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 5.69T | 294.45% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | 1.44T | 31.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 56.52T |
| Celltrion | 38.68T |
| ALTEOGEN | 26.13T |
| SK Biopharmaceuticals | 9.05T |
| Yuhan | 8.83T |
| HLB Co., Ltd. | 6.38T |
| Peptron | 6.31T |
| PharmaResearch | 5.62T |